<- Go Home

Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc. develops sequencing and spatial multiomics technology for researchers and clinicians. The company offers G4 that consists of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California.

Market Cap

$50.8M

Volume

31.6K

Cash and Equivalents

$52.6M

EBITDA

-$87.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$1.4M

Profit Margin

50.77%

52 Week High

$23.41

52 Week Low

$5.34

Dividend

N/A

Price / Book Value

0.41

Price / Earnings

-0.58

Price / Tangible Book Value

0.41

Enterprise Value

-$7.6M

Enterprise Value / EBITDA

0.10

Operating Income

-$91.2M

Return on Equity

53.57%

Return on Assets

-24.21

Cash and Short Term Investments

$114.1M

Debt

$55.7M

Equity

$123.3M

Revenue

$2.7M

Unlevered FCF

-$37.4M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches